Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
International Urology and Nephrology
Published in: International Urology and Nephrology 9/2015

01-09-2015 | Nephrology - Letter to the Editor

A rare case of primary non-function of renal allograft due to adenine phosphoribosyltransferase deficiency

Authors: Benoit Brilland, Jean-François Augusto, Anne Croue, Jean-François Subra, Johnny Sayegh

Published in: International Urology and Nephrology | Issue 9/2015

Login to get access

Excerpt

Editor, …
Literature
1.
Bollee G, Harambat J, Bensman A, Knebelmann B, Daudon M, Ceballos-Picot I (2012) Adenine phosphoribosyltransferase deficiency. Clin J Am Soc Nephrol 7(9):1521–1527CrossRefPubMed
2.
Bouzidi H, Lacour B, Daudon M (2007) 2,8-Dihydroxyadenine nephrolithiasis: from diagnosis to therapy. Annal Biol Clin 65(6):585–592
3.
Harambat J, Bollee G, Daudon M, Ceballos-Picot I, Bensman A, Group AS (2012) Adenine phosphoribosyltransferase deficiency in children. Pediatr Nephrolo 27(4):571–579CrossRef
4.
Glicklich D, Gruber HE, Matas AJ, Tellis VA, Karwa G, Finley K, Salem C, Soberman R, Seegmiller JE (1988) 2,8-dihydroxyadenine urolithiasis: report of a case first diagnosed after renal transplant. Q J Med 68(258):785–793PubMed
5.
Gagné ER, Deland E, Daudon M, Noël LH, Nawar T (1994) Chronic renal failure secondary to 2,8-dihydroxyadenine deposition: the first report of recurrence in a kidney transplant. Am J Kidney Dis 24(1):104–107CrossRefPubMed
6.
de Jong DJ, Assmann KJ, De Abreu RA, Monnens LA, van Liebergen FJ, Dijkman HB, Huysmans FT (1996) 2,8-Dihydroxyadenine stone formation in a renal transplant recipient due to adenine phosphoribosyltransferase deficiency. J Urol 156(5):1754–1755CrossRefPubMed
7.
Brown HA (1998) Recurrence of 2,8-dihydroxyadenine tubulointerstitial lesions in a kidney transplant recipient with a primary presentation of chronic renal failure. Nephrol Dial Transplant 13(4):998–1000CrossRefPubMed
8.
Benedetto B, Madden R, Kurbanov A, Braden G, Freeman J, Lipkowitz GS (2001) Adenine phosphoribosyltransferase deficiency and renal allograft dysfunction. Am J Kidney Dis 37(5):E37CrossRefPubMed
9.
Eller P, Rosenkranz AR, Mark W, Theurl I, Laufer J, Lhotta K (2004) Four consecutive renal transplantations in a patient with adenine phosphoribosyltransferase deficiency. Clin Nephrol 61(3):217–221CrossRefPubMed
10.
Cassidy MJ, McCulloch T, Fairbanks LD, Simmonds HA (2004) Diagnosis of adenine phosphoribosyltransferase deficiency as the underlying cause of renal failure in a renal transplant recipient. Nephrol Dial Transplant 19(3):736–738CrossRefPubMed
11.
Bertram A, Broecker V, Lehner F, Schwarz A (2010) Kidney transplantation in a patient with severe adenine phosphoribosyl transferase deficiency: obstacles and pitfalls. Transpl Int 23(9):e56–e58PubMed
12.
Kaartinen K, Hemmilä U, Salmela K, Räisänen-Sokolowski A, Kouri T, Mäkelä S (2014) Adenine phosphoribosyltransferase deficiency as a rare cause of renal allograft dysfunction. J Am Soc Nephrol 25(4):671–674PubMedCentralCrossRefPubMed
Metadata
Title
A rare case of primary non-function of renal allograft due to adenine phosphoribosyltransferase deficiency
Authors
Benoit Brilland
Jean-François Augusto
Anne Croue
Jean-François Subra
Johnny Sayegh
Publication date
01-09-2015
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 9/2015
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-015-1077-y

Other articles of this Issue 9/2015

International Urology and Nephrology 9/2015 Go to the issue

Nephrology - Original Paper

Tubular proteinuria is the dominant type of proteinuria in an elderly community population in China

Nephrology - Original Paper

Anti-platelet factor 4/heparin antibody is associated with progression of peripheral arterial disease in hemodialysis patients

Nephrology - Original Paper

Achievement of guideline targets in elderly patients on hemodialysis: a multicenter study

Urology - Original Paper

Nocturnal enuresis with spina bifida occulta: Does it interfere behavioral management success?

Urology – Letter to the Editor

A practical solution that bypasses the altruism versus incentives debate

Urology - Original Paper

The effect of pentoxifylline on detrusor muscle contractility after partial urethral obstruction in a rat model
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits